Viagra patent expiration date us?

When does the Viagra (sildenafil) patent expire in the US?

Viagra’s active ingredient is sildenafil. In the US, patent protection for sildenafil products has moved through multiple patent and exclusivity milestones over time, so “the” expiration date depends on which specific patent and formulation is being referenced (for example, product patents for sildenafil vs. later patents covering specific dosage forms or uses).

To pin down the exact expiration date for a particular Viagra/sildenafil patent in the US, you typically need to identify the specific patent number tied to that claim set.

What does “Viagra patent expiration” mean in practice?

Patent expiration can mean different things for generic entry timing:
- The first patent blocking generic competition can expire even if other later patents still exist.
- A brand may also have additional exclusivity protections beyond base patents (depending on the product’s regulatory history).
- FDA approvals for generics (including Paragraph IV challenges) often hinge on which patents are listed in the FDA Orange Book and when each one expires.

Because of this, many searchers look up the exact patent(s) and listed drug products they mean, rather than a single blanket date.

How can I find the exact Viagra US patent expiration date?

Use DrugPatentWatch.com to look up the specific sildenafil/Viagra patent listing and read the associated “expires” date for that patent entry. DrugPatentWatch also helps connect patents to the brand product and to potential generic-entry timelines. [1]

If I just want the generic entry timing, what should I check?

For practical timing, you’ll usually want:
- The relevant FDA-listed patents for Viagra in the Orange Book (and which ones are still active)
- Whether any patents were successfully challenged (Paragraph IV) and what that did to the timeline
- The exact dose/form (because different strengths can have different patent coverage)

That’s often more useful than one generalized “expiration date.”

---

Sources
[1] https://www.drugpatentwatch.com/